Karen A. Foster Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Karen A. Foster is Chief Quality and Operations of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 195,567 shares of BLFS, which is worth approximately $4.32 Million. The most recent transaction as insider was on Aug 31, 2022, when has been sold 299 shares (Common Stock) at a price of $23.44 per share, resulting in proceeds of $7,009. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 196K
24.85% 3M change
22.89% 12M change
Total Value Held $4.32 Million

Karen A. Foster Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 31 2022
SELL
Open market or private sale
$7,009 $23.44 p/Share
299 Reduced 0.27%
109,373 Common Stock
Aug 14 2022
BUY
Grant, award, or other acquisition
-
278 Added 0.25%
109,672 Common Stock
Aug 10 2022
SELL
Open market or private sale
$2,201 $23.17 p/Share
95 Reduced 0.09%
109,394 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
-
355 Added 0.32%
109,489 Common Stock
Jul 17 2022
BUY
Grant, award, or other acquisition
-
430 Added 0.39%
109,134 Common Stock
Jul 03 2022
BUY
Grant, award, or other acquisition
-
468 Added 0.43%
108,704 Common Stock
Jun 28 2022
SELL
Open market or private sale
$8,886 $14.86 p/Share
598 Reduced 0.55%
108,236 Common Stock
Jun 19 2022
BUY
Grant, award, or other acquisition
-
497 Added 0.45%
108,834 Common Stock
Jun 05 2022
BUY
Grant, award, or other acquisition
-
498 Added 0.46%
108,337 Common Stock
May 27 2022
SELL
Open market or private sale
$2,528 $14.53 p/Share
174 Reduced 0.16%
107,839 Common Stock
May 22 2022
BUY
Grant, award, or other acquisition
-
533 Added 0.49%
108,013 Common Stock
May 13 2022
SELL
Open market or private sale
$715 $12.32 p/Share
58 Reduced 0.05%
107,480 Common Stock
Apr 18 2022
SELL
Open market or private sale
$288,705 $17.59 p/Share
16,413 Reduced 13.24%
107,538 Common Stock
Apr 12 2022
BUY
Exercise of conversion of derivative security
-
38,836 Added 23.86%
123,951 Common Stock
Mar 29 2022
SELL
Open market or private sale
$12,165 $22.24 p/Share
547 Reduced 0.64%
85,115 Common Stock
Mar 01 2022
SELL
Open market or private sale
$5,255 $23.78 p/Share
221 Reduced 0.32%
69,306 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
16,356 Added 16.0%
85,883 Common Stock
Feb 10 2022
SELL
Open market or private sale
$8,608 $29.38 p/Share
293 Reduced 0.42%
69,527 Common Stock
Dec 29 2021
SELL
Open market or private sale
$24,606 $39.37 p/Share
625 Reduced 0.89%
69,820 Common Stock
Nov 30 2021
SELL
Open market or private sale
$11,841 $37.59 p/Share
315 Reduced 0.45%
70,445 Common Stock
Nov 22 2021
SELL
Open market or private sale
$754,375 $46.19 p/Share
16,332 Reduced 18.75%
70,760 Common Stock
Nov 22 2021
BUY
Exercise of conversion of derivative security
$26,784 $1.64 p/Share
16,332 Added 15.79%
87,092 Common Stock
Oct 25 2021
SELL
Open market or private sale
$725,957 $44.45 p/Share
16,332 Reduced 18.75%
70,760 Common Stock
Oct 25 2021
BUY
Exercise of conversion of derivative security
$26,784 $1.64 p/Share
16,332 Added 15.79%
87,092 Common Stock
Oct 14 2021
SELL
Open market or private sale
$43,248 $39.97 p/Share
1,082 Reduced 1.51%
70,760 Common Stock
KAF

Karen A. Foster

Chief Quality and Operations
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS